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Abstract
Background: Low-fat (LF) and high-fat (HF) weight loss diets improve brachial artery flow-mediated dilation (FMD)
in obese individuals, although results are conflicting. Moreover, the role that adipose tissue plays in mediating
these diet-related effects are unknown.
Objective: This study examined how modulations in FMD by HF and LF diets relate to changes in adipocyte
parameters.
Design: Obese subjects (n = 17) were randomized to a HF diet (60% kcal as fat) or a LF diet (25% kcal as fat) for
6 weeks. Both groups were restricted by 25% of energy needs.
Results: Body weight decreased (P <0.05) in both groups (HF: -6.6 ± 0.5 kg, LF: -4.7 ± 0.6 kg). Fat mass and waist
circumference were reduced (P <0.05) in the LF group only (-4.4 ± 0.3 kg; -3.6 ± 0.8 cm, respectively). FMD
improved (P <0.05) in the LF group (7.4 ± 0.8% to 9.8 ± 0.8; 32% increase) and was impaired in the HF group
(8.5 ± 0.6% to 6.9 ± 0.7; 19% reduction). Increases in plasma adiponectin (P <0.05, 16 ± 5%), and decreases in
resistin (P <0.05, -26 ± 11%), were shown by the LF diet only. Greater decreases in leptin were observed with LF
(-48 ± 9%) versus HF (-28 ± 12%) (P <0.05, diet × time). Increased FMD by the LF diet was associated with
increased adiponectin, and decreased fat mass, waist circumference, leptin, and resistin.
Conclusion: Beneficial modulations in vascular health by LF diets may be mediated by improvements in adipocyte
parameters.
Introduction
Obesity is a key risk factor for the development of cor-
onary heart disease (CHD). Patients who are obese often
exhibit increased LDL cholesterol and triglyceride con-
centrations, reduced HDL cholesterol concentrations,
and increased blood pressure [1]. Carrying this extra
weight also leads to abnormal endothelial function
marked by reduced vasodilation to an increased blood
flow (endothelium-dependent flow-mediated dilation;
FMD) [2]. Endothelial dysfunction is an early hallmark
and prognostic indicator of future CHD, and most
vascular disease risk factors are associated with reduced
FMD [3].
Weight loss has been shown to improve plasma lipids,
blood pressure, and endothelial function in obese sub-
jects [4]. However, some controversy exists as to the opti-
mal macronutrient composition of the weight loss diet to
improve vascular health. For instance, in a study by Phil-
lips et al. [5], 6 weeks of a calorie-restricted high-fat
(HF), low carbohydrate diet (60% of kcal as fat, 25% kcal
as saturated fat) impaired FMD, while an isocaloric low-
fat diet (LF) (25% of kcal as fat, 7% kcal as saturated fat)
was shown to improve FMD. In contrast, Volek et al. [5],
report increases in FMD with a HF diet, and decreases
with a LF diet, while Keogh et al. [6,7] demonstrate no
effect of either diet on vascular endothelial function dur-
ing weight loss. In view of these contradictory findings,
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more work in this area is evidently required before solid
conclusions can be reached.
The mechanisms that link weight loss to improve-
ments in endothelial function are still unclear. However,
recent evidence suggests that adipose tissue physiology
(i.e. adipokine profile and visceral adiposity) may play a
role. Adiponectin is a fat cell-derived hormone that pro-
tects the endothelium by decreasing oxidative stress [8].
This hormone has been shown to increase with weight
loss and is inversely related to waist circumference
(indirect measure of visceral fat mass) [9]. Leptin and
resistin, in contrast, are pro-atherogenic hormones
derived from adipocytes that have been shown to cause
endothelial dysfunction by promoting oxidative stress
[10,11]. Leptin and resistin decrease with weight loss
and are positively correlated to visceral fat mass [9]. As
such, weight loss interventions that reduce visceral fat
mass generally result in increased plasma adiponectin,
and decreased leptin and resistin. This favorable adipo-
kine profile has a protective effect on the vascular
endothelium, which results in increased FMD [12]. An
important question that has yet to be tested is whether
the enhancements in FMD that occur with either LF or
HF diets during weight loss, are mediated in part by
improvements in adipocyte parameters.
Accordingly, the objective of this study was to exam-
ine the intermediate role of adipocyte parameters in
mediating the effects of HF versus LF diets on vascular
health during weight loss.
Subjects and methods
Subjects
The study flow chart detailing subject screening, rando-
mization and withdrawals is displayed in Figure 1. Sub-
jects were recruited by means of flyers. Key inclusion
criteria were as follows: age 18 to 50 years; body mass
index (BMI) between 30 and 39.9 kg/m2; normocholes-
terolemic (defined as total cholesterol concentrations
below 200 mg/dl); non-smoking; free of cardiovascular
disease; non-diabetic; no history of disordered eating;
not dieting; no weight gain or loss > 6 kg in the 3
months prior to the study; not taking lipid or glucose
lowering medications; no history of elevated blood pres-
sure (defined as systolic blood pressure >150 mm Hg;
diastolic blood pressure >90 mm Hg); and not pregnant
or lactating. In addition, peri-menopausal women were
excluded from the study, and post-menopausal women
(defined as an absence of menses for > 2 years) were
required to maintain their current hormone replacement
therapy regimen for the duration of the study. The
experimental protocol was approved by the Office for
the Protection of Research Subjects at the University of
Illinois, Chicago. All volunteers gave their written
informed consent to participate in the trial prior to the
commencement of the study.
Experimental design
A 6-week randomized, parallel-arm, dietary intervention
trial was implemented to test the study objectives. Sub-
jects were randomized to 1 of 2 dietary weight loss
groups: 1) HF diet, or 2) LF diet. Random assignment
was accomplished with a 1:1 treatment assignment ratio
using an envelope-based randomization. Envelopes con-
taining diet assignments were prepared by non-study
personnel, sequentially numbered, and identically sealed.
High-fat and low-fat weight loss diet protocols
All foods and beverages were prepared in the metabolic
kitchen of the Clinical Research Center (CRC) and dis-
tributed to participants 3 times per week. Subjects in
both groups were restricted by 25% of their baseline
energy needs. Resting energy expenditure (REE) was
measured after a 12-h fast by indirect calorimetry using
a metabolic monitor as previously described [13]. The
calorie-reduced diets comprised solid foods, typical of
those consumed in North America, and were provided
as a 3-d rotating menu. All participants were provided
with a daily multivitamin and mineral tablet throughout
the duration of the study. The macronutrient and diet-
ary composition of each diet is reported in Table 1.
Dietary compliance and physical activity assessment
The subjects were instructed to eat only the foods pro-
vided and to abstain from alcohol throughout the study.
Compliance with the experimental diet was assessed by
means of daily recording of added and missed foods
from the menu plan. If the deviations averaged > 5%
of total calories each day, the subject was considered
noncompliant and the data were not included in the
analyses. Dietary compliance was also assessed by mea-
suring the ratio of urinary urea to creatinine. A 24-h
urine sample was collected at week 1 and 6 for the
assessment of sodium excretion and urea/creatinine
ratio. The urine volume was recorded and aliquots were
frozen until analysis. Urea and creatinine were measured
using enzymatic kits (Roche Diagnostics, Indianapolis,
IN). Subjects were also instructed to maintain their cus-
tomary level of physical activity throughout the duration
of the study. An electronic pedometer was used for the
quantitative measurement of changes in physical activity.
Study participants were instructed (including a demon-
stration) how to use the pedometer properly, according
to the manufacturer’s instructions. All study participants
wore the pedometer each day of the 6-week study, and
were instructed to record step counts in a log at the
end of each day.
Varady et al. Nutrition Journal 2011, 10:8
http://www.nutritionj.com/content/10/1/8
Page 2 of 9
Figure 1 Study flow chart.
Table 1 Macronutrient and dietary composition of provided calorie-reduced diets 1
Macronutrient composition HF diet LF diet
Energy (kcal) 1868 ± 106 1967 ± 93
Carbohydrate (% kcal) 5 ± 1 55 ± 2
Protein (% kcal) 35 ± 1 20 ± 1
Protein-energy ratio (g/100 kcal) 8.7 ± 1 4.8 ± 1
Fat (% kcal) 60 ± 1 25 ± 1
Saturated fat (% kcal) 26 ± 1 7 ± 1
Monounsaturated fat (% kcal) 24 ± 1 9 ± 1
Polyunsaturated fat (% kcal) 9 ± 1 9 ± 1
Trans fat (% kcal) 1 ± 0 0 ± 1
Cholesterol (mg) 448 ± 14 299 ± 3
Fiber (g) 11 ± 2 30 ± 2
Dietary composition HF diet LF diet
Breakfast Eggs Oatmeal
Ham Canned peaches
Lunch Lettuce w/carrots and cucumber Lettuce w/carrots and cucumber
Roast beef Tuna
Cheddar cheese Walnuts
Olive oil/vinegar dressing Ranch dressing
Dinner Chicken provencal Macaroni with beef
Potatoes w/butter Dinner roll
Broccoli Broccoli
1 Data are presented as mean ± SEM. HF: high fat, LF: low fat.
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Blood collection protocol
Twelve-hour fasting blood samples were collected at
week 1 (day 1) and at week 6 (day 42). Blood was cen-
trifuged for 15 min at 520 × g and 4°C to separate
plasma from red blood cells, and was stored at -80°C.
Body weight and body composition assessment
Body weight was assessed in the fasted state without shoes
and in light clothing at week 1 and 6, using a balance
beam scale (Health-O-Meter, Terre Haute, IN). Height
was measured using a wall-mounted stadiometer. BMI
was calculated as kg/m2. Fat mass and fat free mass were
assessed in triplicate after each weigh-in using a tetra-
polar bioelectrical impedance analyzer (Xitron, San Diego,
CA). The instrument recorded impedance from hand to
foot and consequently, calculated fat mass and fat free
mass from the impedance value and the pre-entered per-
sonal particulars (weight, height, age and sex). The coeffi-
cient of variation within run for percent body fat was
3.1%. Waist circumference was measured in triplicate in
standing subjects as the minimum abdominal circumfer-
ence between the xyphoid process and the umbilicus [14].
Brachial artery measurements of flow-mediated dilation
(FMD)
Brachial artery FMD was assessed at week 1 and 6.
Ultrasound imaging of the brachial artery (Logiq 500
Pro Ultrasound System, General Electric COmpany,
Schenectady, NY) was performed in a longitudinal plane
at a site 1-3 cm proximal to the antecubital fossa, with
the arm abducted approximately 80° from the body and
the forearm supinated. The ultrasound probe (11 MHz)
was positioned to visualize the anterior and posterior
lumen-intima interfaces to measure diameter or central
flow velocity (pulsed Doppler). After baseline images
were recorded, a blood pressure cuff on the forearm was
inflated to 200 mm Hg for 5 min. To assess FMD, 10
seconds of images were captured at a rate of 10 images/
second, 30 seconds, 1 min, and 2 min after cuff release.
Images were digitally recorded using Brachial Imager
(Medical Imaging, Iowa City, Iowa) at 10 frames per
second for 10 seconds at each time period. Brachial
artery diameter was measured from the intimal medial
border interface on each frame using the average of 100
distinct evenly spaced longitudinal diameters for each
measurement using an automated edge-detection algo-
rithm. The minimum (diastolic) diameters were deter-
mined for each cardiac cycle and these minimum
diameters (n = 8-10) were then averaged to obtain one
brachial artery diameter at each time point. Percent
FMD was calculated using the averaged minimum mean
brachial artery diameter at baseline compared to the lar-
gest mean values obtained after either release of the
forearm occlusion. Percent FMD was calculated using
the averaged minimum mean brachial artery diameter at
baseline compared to the largest mean values obtained
after release of the forearm occlusion.
Plasma adipokine determination
Plasma adiponectin, leptin, and resistin concentrations
were quantified using high sensitivity ELISA kits (R&D
Systems, Minneapolis, MN). Intra-assay precision of the
adiponectin, leptin, and resistin ELISA kits were 4.1%,
3.8%, and 4.2%, respectively.
Cardio-metabolic risk factor assessment
Total cholesterol, direct LDL cholesterol, HDL choles-
terol, and triacylglycerol concentrations were measured
using enzymatic kits (Roche Diagnostics, Indianapolis,
IN), with intra-assay variances of 3.7%, 3.7%, 4.1%, and
2.6%, respectively. Blood pressure was measured after a
5-min rest after the weigh-in. C-reactive protein (CRP)
was measured by ELISA, (R&D Systems Inc., Minneapo-
lis, MN), with an intra-assay variance of 3.0%. Plasma
glucose concentration was measured using the glucose
oxidase procedure (Beckman II autoanalyzer), and
plasma insulin was measured by radioimmunoassay
(Linco Research, MO), with intra-assay variances of
3.8% and 4.3%, respectively.
Statistical analysis
Data are presented as mean ± SEM. All variables were
examined for a normal distribution, and abnormally
distributed variables were log-transformed. One-factor
analysis of variance was used to compare baseline charac-
teristics. The effect of the dietary intervention was
assessed by using repeated-measures analysis of variance,
with time as the within-subject factor and diet (HF com-
pared with LF) as the between-subjects factor. Post hoc
comparisons were performed by Tukey’s honestly signifi-
cant difference test. Correlation analysis was used to
determine relationships between variables. Statistical sig-
nificance was set at P < 0.05. Data were analyzed using
SPSS software (version 18.0; SPSS Inc, Chicago, IL).
Results
Subject baseline characteristics and dropouts
Twenty subjects commenced the study, with 17 com-
pleting the entire 6-week trial (HF group, n = 9; LF
group, n = 8) (Figure 1). Two subjects dropped out due
to scheduling problems, while one other dropped out
due to inability to comply with the LF diet protocol. No
significant differences in baseline variables were
observed between groups (Table 2).
Dietary compliance and physical activity
Adherence to the dietary interventions was established
by the ratio of urinary urea to creatinine. The ratio was
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not different between groups at baseline (HF: 35 ± 4; LF:
31 ± 2, P = 0.16) but was significantly different between
diets at week 6 (HF: 40 ± 2; LF: 31 ± 3, P = 0.04 for
diet × time interaction). Changes in physical activity,
assessed by wearing a pedometer each day, were not dif-
ferent between groups throughout the trial (HF: 9754 ±
2256 steps/d; LF: 10090 ± 1842 steps/d, P = 0.35).
Changes in body weight and body composition by HF
versus LF diets
Body weight was reduced (P < 0.05) in both the HF and
LF groups by week 6 (Table 3). However, the HF group
lost significantly more weight from baseline (-6.6 ± 0.5
kg) than the LF group (-4.7 ± 0.6 kg) (P <0.05 for diet ×
time interaction). BMI decreased (P <0.05) in both the
HF (-2.0 ± 0.2 kg/m2) and LF group (-1.7 ± 0.2 kg/m2)
after 6 weeks of diet. Fat mass and waist circumference
were reduced (P <0.05) in the LF group only (-4.4 ± 0.3
kg; -3.6 ± 0.8 cm, respectively). As for fat free mass,
decreases from baseline (P <0.05) were observed only
for the HF group (-3.0 ± 0.2 kg).
Improvements in vascular endothelial function by HF
versus LF diets
There were no differences in brachial artery FMD
between groups at baseline (Figure 2). By week 6, FMD
improved (P <0.05) in the LF group relative to baseline
(7.4 ± 0.8% to 9.8 ± 0.8; 32% increase). In contrast,
FMD was impaired (P <0.05) in the HF group by week
6 relative to baseline (8.5 ± 0.6% to 6.9 ± 0.7; 19%
reduction).
Plasma adipokine changes by HF versus LF diets
After 6 weeks of diet, circulating adiponectin increased
(P <0.05) with weight loss in the LF group (16 ± 5%),
but remained unchanged in the HF group (Figure 3).
Leptin concentrations were reduced (P <0.05) with
weight loss in both the HF group (-28 ± 12%) and LF
group (-48 ± 9%). However, the LF group experienced
greater decreases in leptin from baseline than the HF
group (P <0.05 for diet × time interaction). Plasma
resistin decreased (P <0.05) with weight loss in the LF
group only (-26 ± 11%).
Relationship between vascular endothelial function and
adipose tissue parameters
After 6 weeks of diet, increased FMD by the LF diet was
associated with increased adiponectin, and decreased fat
mass, waist circumference, leptin, and resistin (Table 4).
There were no significant associations between FMD
and any of these adipose tissue variables in the HF
group (data not shown).
Cardio-metabolic risk modulations by HF versus LF diets
Total and LDL cholesterol were lower (P <0.05) after
6 weeks of diet in the LF group (Table 5). In contrast,
total cholesterol increased (P <0.05) with weight loss in
HF group, while LDL cholesterol was not affected. Tria-
cylglycerols and HDL cholesterol concentrations were
not altered by either intervention. Plasma lipids were
not correlated with FMD at baseline or post-treatment.
Systolic blood pressure was lower (P <0.05) with weight
loss in both groups, but decreased more with the LF
Table 2 Baseline characteristics of subjects who







Age (y) 35 ± 3 36 ± 3
Body weight (kg) 97 ± 5 98 ± 4
BMI (kg/m2) 33 ± 1 34 ± 2
Total cholesterol (mg/dL) 147 ± 11 152 ± 10
LDL cholesterol (mg/dL) 82 ± 10 95 ± 8
HDL cholesterol (mg/dL) 57 ± 5 47 ± 4
Triacylglycerol (mg/dL) 75 ± 14 62 ± 8
Systolic blood pressure (mm Hg) 125 ± 5 131 ± 7
Diastolic blood pressure (mm Hg) 72 ± 3 75 ± 3
Steps per day 9974 ± 2701 10257 ± 2862
1 Data are presented as mean ± SEM.HF: high fat, LF: low fat.
2 No differences between HF and LF group for any baseline characteristic.
Data were analyzed using One-factor ANOVA.





Week 1 Week 6 Week 1 Week 6
Body weight (kg) 97.0 ± 4.5 90.4 ± 4.32,3 98.3 ± 3.9 93.6 ± 4.02
BMI (kg/m2) 32.5 ± 1.0 30.5 ± 1.02 34.4 ± 1.5 32.7 ± 1.92
Fat mass (kg) 41.8 ± 1.6 39.5 ± 1.4 41.0 ± 1.5 36.6 ± 1.52
Fat free mass (kg) 53.8 ± 4.0 50.8 ± 3.42 57.3 ± 2.5 56.9 ± 2.5
Waist circumference (cm) 97.3 ± 2.3 95.8 ± 1.9 98.5 ± 2.7 94.9 ± 1.62
1Data are presented as mean ± SEM. HF: high fat, LF: low fat. Data were analyzed using repeated-measures ANOVA.
2P <0.05 for main effect of time.
3P < 0.05 for diet × time interaction such that HF group had greater reductions in body weight than the LF group.
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diet (P <0.05 for diet × time interaction). Similar reduc-
tions (P <0.05) in diastolic blood pressure values were
noted for the HF and LF diet. Glucose was not affected
by either diet, while insulin decreased (P <0.05) in both
diet groups. CRP concentrations did not change with
either diet.
Discussion
This study is the first to show that improvements in
endothelial function by LF diets during weight loss may
be mediated in part by changes in adipose tissue biol-
ogy. More specifically, we show here that improved bra-
chial artery FMD during LF diets is associated with
decreased visceral fat mass and improved adipokine pro-
file (i.e. increased plasma adiponectin, and decreased
leptin and resistin). These benefits of LF diets on vascu-
lar health were paralleled by improvements in several
CHD risk factors. In contrast, weight loss by HF diets,
were shown to impair FMD, with no concomitant
improvement in parameters of adipocyte biology.
Brachial artery FMD is a noninvasive index of
endothelial function [15], and is an independent predic-
tor of cardiovascular events [16]. Diet-induced weight
loss has been shown to be an effective strategy to help
obese individuals increase FMD, however, the optimal
macronutrient composition of the diet remains
unknown. While some studies indicate that LF diets
may benefit vascular health more than HF diets [17,18],
other studies show that HF diets are superior [5]. In the
present study, we demonstrate that weight loss resulting
from an LF diet improves FMD, while weight loss
resulting from a HF diet impairs FMD. Although these
findings are similar to that of Phillips et al. [17], they
are in contrast to the results of Keogh et al. [6,7] and
Volek et al. [5]. The reason for these conflicting data
remain unclear since trial design in each study was simi-
lar with respect to sample population, trial length, and
dietary macronutrient distribution. One key difference,
however, is the dietary protocols used. In our study, as
well as in the study by Phillips et al. [17], all meals were
provided to the subjects so that macronutrient distribu-
tion would be carefully controlled. In the trials by
Keogh et al. [6,7] and Volek et al. [5], subjects were
Figure 2 Flow-mediated dilation during the 6-week trial. Data
are presented as mean ± SEM. HF: high fat, LF: low fat. HF group
(n = 9), LF group (n = 8). Data were analyzed using repeated-
measures ANOVA. *P <0.05 for main effect of time.
Figure 3 Plasma adipokines during the 6-week trial. Data are
presented as mean ± SEM. HF: high fat, LF: low fat. HF group (n =
9), LF group (n = 8). Data were analyzed using repeated-measures
ANOVA. *P <0.05 for main effect of time.
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instructed how to consume the HF or LF diets by a die-
tician, and dietary adherence was assessed by means of
food records. Since macronutrient distribution was not
carefully controlled in the studies by Keogh et al. [6,7]
and Volek et al. [5], it is possible that the subjects were
consuming something closer to a standard diet (i.e. 50%
kcal as carbohydrate, 15% kcal as protein, and 35% kcal
as fat), rather than a HF or LF diet. As such, the lack of
standardization of the feeding protocols may partly
explain these inconsistent findings. The reason why the
HF diet impaired FMD is not certain, but may involve
the increased consumption of saturated fat. Subjects in
the HF group consumed 26% of energy as saturated fat,
which is similar to that consumed with Atkins’-like
diets. Evidence suggests that a high intake of saturated
fat directly impairs arterial endothelial function by redu-
cing the anti-inflammatory potential of HDL [19].
Therefore, the increased saturated fat intake may have
contributed to the decreased FMD observed in the HF
group. It should also be noted that the diets varied
greatly in dietary fiber content (HF diet: 11 g/d, LF diet:
30 g/d). Recent findings by Rallidis et al. [20] indicate
that increasing fiber consumption may augment FMD in
obese volunteers. As such, this discrepancy in dietary
fiber content between the two groups may have contrib-
uted to the beneficial alterations in FMD observed by
the LF diet, but not the HF diet.
The differences in endothelial function observed
between HF and LF groups may also be related to
changes in body composition. We show here that HF
subjects lost more weight (-6.6 ± 0.5 kg) than LF sub-
jects (-4.7 ± 0.6 kg). However, fat mass and waist cir-
cumference were significantly decreased in LF subjects
only. It was also observed that the decreases in fat mass
and waist circumference by LF diets were correlated to
improvements in FMD post-treatment. Accumulating
evidence suggests that visceral fat mass is inversely cor-
related to FMD [21]. A mechanism linking visceral adip-
osity to the onset and progression of endothelial
dysfunction may involve free fatty acids (FFA) [22]. In
vitro studies demonstrate that excessive release of FFA
by visceral fat into the bloodstream can enhance the
production of reactive oxygen species, which may induce
endothelial dysfunction [23]. In view of these relation-
ships, it is possible that the decrease in visceral fat mass
in the LF group contributed to the improvements in
FMD observed here. It is important to note, however,
that this study is limited in that waist circumference was
used to assess visceral fat mass. Waist circumference is
only an indirect indicator of visceral adiposity, and is
strongly operator dependent. As such, future studies in
this area should implement computed tomography (CT)
scans to distinguish between visceral and subcutaneous
fat mass, and to confirm the association of visceral adip-
osity with FMD.
Favorable changes in adipokine profile may have also
played a role in the improvements in FMD observed with
LF diets. After 6-weeks of treatment, subjects in the LF
group experienced a 16% increase in plasma adiponectin
from baseline, which was paralleled by a 48% and 26%
decrease in leptin and resistin concentrations, respec-
tively. We also observed that the increases in adiponectin,
and decreases in leptin and resistin were associated with
improved FMD. Although a causal link between adipo-
nectin and FMD has yet to be established, we speculate
that modulations in nitric oxide (NO) by adiponectin
may be involved. Nitric oxide, released from the endothe-
lium, is important in regulating vascular tone. Plasma
adiponectin can stimulate the phosporylation of endothe-
lial nitric oxide synthase (eNOS), thereby increasing NO-
dependent endothelial vasodilation [24]. Therefore,
higher circulating concentrations of adiponectin in the
LF group may contribute to enhanced endothelial func-
tion. As with adiponectin, we hypothesize that the
Table 4 Changes in FMD relative to changes in adipose tissue parameters in the LF group at week 6 1
Δ Body weight Δ Fat mass Δ WC Δ Adiponectin Δ Leptin Δ Resistin
FMD r = -0.15 r = -057 r = -0.81 r = 0.55 r = -0.78 r = -0.47
P = 0.72 P = 0.04 P = 0.01 P = 0.04 P = 0.03 P = 0.01
1 Δ: percent change from baseline, FMD: flow-mediated dilation, WC: waist circumference.






Week 1 Week 6 Week 1 Week 6
Total cholesterol (mg/dL) 147 ± 11 162 ± 72 152 ± 10 139 ± 72
LDL cholesterol (mg/dL) 82 ± 10 90 ± 14 95 ± 8 86 ± 102
HDL cholesterol (mg/dL) 57 ± 5 56 ± 5 47 ± 4 40 ± 2
Triacylglycerols (mg/dL) 75 ± 14 57 ± 10 62 ± 8 74 ± 10
SBP (mm Hg) 125 ± 5 114 ± 32 131 ± 8 115 ± 32,3
DBP (mm Hg) 72 ± 3 67 ± 32 75 ± 3 68 ± 42
Glucose (mg/dL) 92 ± 1 96 ± 2 90 ± 2 91 ± 2
Insulin (mg/dL) 19 ± 3 13 ± 12 18 ± 5 14 ± 22
CRP (mg/dL) 6 ± 1 7 ± 1 5 ± 2 5 ± 2
1Data are presented as mean ± SEM. CRP: C-reactive protein, DBP: diastolic
blood pressure, HF: high fat, LF: low fat, SBP: systolic blood pressure. Data
were analyzed using repeated-measures ANOVA.
2P <0.05 for main effect of time.
3P <0.05 for diet × time interaction such that LF group had greater reductions
in systolic blood pressure than the HF group.
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mechanism linking decreased leptin and resistin to
increased FMD may involve changes in the production of
NO. Both leptin and resistin have been shown to blunt
NO production [11,25] likely through the stimulation of
reactive oxygen species that scavenge NO and impair
eNOS function. Since these adipokines were significantly
decreased post-intervention in the LF group, there would
be less leptin and resistin in the circulation to inhibit
NO. Therefore, more NO may have been produced,
resulting in an enhancement in endothelium-dependent
vasodilation. Visceral fat mass loss is a major determinant
of adipokine profile improvement with diet [26]. In the
present study, significant reductions in visceral fat mass
were noted in the LF group, but not the HF group. As
such, it can be hypothesized that this reduction in
abdominal fat mass by the LF regimen contributed to the
increases in adiponectin, and decreases in leptin and
resistin observed.
Several previous studies have evaluated the effects of
HF and LF energy restricted diets on cardiometabolic
disease risk factors [5-7,17]. In general, both of these
diets have been shown to improve blood pressure, CRP,
glucose, and insulin concentrations [5-7,17]. We show
here that HF and LF diets were equally as effective in
reducing blood pressure (systolic and diastolic) and
insulin. However, differential effects for each diet on
plasma lipids were observed. For instance, in the LF
group, total and LDL cholesterol concentrations were
reduced post-intervention. In contrast, in the HF group,
total cholesterol increased while LDL cholesterol
remained unchanged. These effects of HF diets on cho-
lesterol concentrations are in line with previous findings
[27]. Diets that are high in saturated fat are thought to
increase total and LDL cholesterol concentrations by
affecting LDL receptor activity, protein, and mRNA
abundance [28]. These mechanisms may therefore
account for the increased total cholesterol concentra-
tions observed with HF diets.
There are several limitations to our study that warrant
discussion. Firstly, our study is limited in that it
employed a small sample size (HF diet: n = 9, LF diet:
n =8). This imposes risk of a type 2 error, and as such,
non-significant results may be merely the result of low
statistical power. An example of this would be the lack
of significant difference for FMD at baseline between
groups. If a larger sample size was employed, it can be
postulated that a significant difference in FMD between
groups at this time point would be observed. Secondly,
our experimental design is limited in that no control
group was implemented. The omission of a control
group makes it difficult to ascertain whether these
effects were truly due to treatment, and not the result
of an unidentified confounder. Future studies in this
area should include a control group to ensure that
these effects can be solely attributed to diet. Thirdly,
our findings cannot be generalized to all HF and LF
diets. Since not all HF and LF diets are created equal, it
is possible that these effects may have occurred in
response to the specific diets and food items provided
here.
In sum, our findings suggest that weight loss with LF
diets may be superior to that of HF diets for improving
endothelial function and cardiometabolic risk variables.
Our results also show that these vascular benefits of LF
diets may be mediated, in part, by improvements in adi-
pose tissue parameters (i.e. body fat distribution and
adipokine profile). Further research is warranted to
determine the impact of both dietary patterns on long-
term cardiovascular outcomes, and the role that adipose
tissue may play in mediating these effects.
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